Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

Background Immunosuppression and comorbidities increase the risk of severe coronavirus
disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of …

Strategies to prevent infection and improve outcomes in patients with cirrhosis. HAV,
hepatitis A virus; HBV, hepatitis B virus; COVID-19, novel coronavirus disease 2019; NSBB …

Background COVID-19 continues to pose a significant healthcare challenge throughout the
world. Comorbidities including diabetes and hypertension are associated with a significantly …

Since identified in December 2019, COVID-19 has remained a pandemic across the globe.
Although primarily a respiratory illness, the impact of COVID-19 on other end organs has …

Background and aims Recent studies have reported poor humoral immune response to
mRNA vaccines in patients with chronic liver disease (CLD). However, the immunogenicity …

There is an ongoing need to understand whether transplantation during acute Coronavirus
disease 2019 (COVID‐19) can be performed safely, especially when urgent transplant is …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that
is responsible for causing coronavirus disease-2019 (COVID-19). SARS-CoV-2 was first …

Abstract Purpose of Review As the coronavirus disease 2019 (COVID-19) pandemic
continues to surge, determining the safety and timing of proceeding with solid organ …

Our transplant recipients require a three-dose mRNA or adenovirus-vector and one dose of
mRNA vaccine to be optimally protected initially; they then need to receive a bivalent …